Help us improve our website

Search

Type

Audience

Category

Issue

Last updated

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.

Displaying 1 - 15 of 23 items.

" " COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation for Use in Children Aged 5 Years to Less Than 12 Years
IMPORTANT: Access to Canadian-specific labelling information during the distribution of COMIRNATY (COVID-19 Vaccine, mRNA also referred to as Pfizer-BioNTech COVID-19 Vaccine) for Children Aged 5 Years to Less Than 12 Years.   Audience…
AlertHealth professional risk communication | 2021-11-19
" " Distribution of SPIKEVAX (elasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels
IMPORTANT: Access to Canadian-specific labelling information during the distribution of the SPIKEVAX (elasomeran) COVID-19 Vaccine with English-only vial and carton labels. Audience Healthcare professionals including infectious disease physicians,…
AlertHealth professional risk communication | 2021-11-10
" " Health Canada is updating the labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines
Health Canada is informing Canadians and healthcare professionals about changes to the product labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines. The Department is updating the label of the Janssen COVID-19 Vaccine to provide…
AlertPublic advisory | 2021-11-09
" " Importation of Janssen COVID-19 Vaccine with European Union (EU) English-only Vial and Carton Labels
IMPORTANT: Access to storage and expiry date instructions during the distribution of the Janssen COVID-19 Vaccine with EU English-only labels. Audience Healthcare professionals including infectious disease physicians, pharmacists, family…
AlertHealth professional risk communication | 2021-11-05
" " Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic
Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic Starting date: September 22, 2021 Posting date: October 4, 2021 Type of communication:…
AlertHealth professional risk communication | 2021-10-04
" " One lot of the hypoglycemia treatment Glucagon recalled as it may pose serious health risks
One lot of the hypoglycemia treatment Glucagon recalled as it may pose serious health risks Starting date: September 25, 2021 Posting date: September 25, 2021 Type of…
AlertPublic advisory | 2021-09-25
" " Health Canada updates Pfizer-BioNTech COVID-19 vaccine label to reflect very rare reports of Bell's Palsy
Health Canada updates Pfizer-BioNTech COVID-19 vaccine label to reflect very rare reports of Bell's Palsy Starting date: August 6, 2021 Type of communication: Advisory…
AlertPublic advisory | 2021-08-06
" " Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic Starting date: July 30, 2021 Posting date: July 30, 2021 Type…
AlertHealth professional risk communication | 2021-07-30
" " Health Canada updates Pfizer-BioNTech and Moderna COVID-19 vaccine labels to include information on myocarditis and pericarditis
Health Canada updates Pfizer-BioNTech and Moderna COVID-19 vaccine labels to include information on myocarditis and pericarditis Starting date: June 30, 2021 Posting date:…
AlertPublic advisory | 2021-06-30
" " AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome Starting date: June 29, 2021 Posting date: June 29, 2021 Type of communication: Dear Healthcare…
AlertHealth professional risk communication | 2021-06-29
" " Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines
Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines Starting date: April 14, 2021 Posting date: June 29, 2021 Type of communication: Advisory…
AlertPublic advisory | 2021-06-29
" " Importation of COVID-19 Vaccine Moderna with up to 15 Doses per Vial and English-only Vial and Carton Labels (US-Labelled Supply)
UPDATED INFORMATION – October 29, 2021 Further to the Health Canada communications below issued on June 14, 2021 (and updated on June 24, 2021, and August 3, 2021), Health Canada has authorized a 2-month shelf life extension (from 7 months to 9 months…
AlertHealth professional risk communication | 2021-06-14
" " Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants Starting date: April 28, 2021 Posting date: April 28, 2021 Type of…
AlertHealth professional risk communication | 2021-04-28
" " Importation of Janssen COVID-19 Vaccine with Two Types of English-only Vial and Carton Labels
Importation of Janssen COVID-19 Vaccine with Two Types of English-only Vial and Carton Labels Starting date: April 26, 2021 Posting date: April 26, 2021 Type of communication…
AlertHealth professional risk communication | 2021-04-26
" " Janssen COVID-19 Vaccine and the Risk of Thrombosis with Thrombocytopenia
Janssen COVID-19 Vaccine and the Risk of Thrombosis with Thrombocytopenia Starting date: April 26, 2021 Posting date: April 26, 2021 Type of communication: Dear Healthcare…
AlertHealth professional risk communication | 2021-04-26
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.